Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

teva pharma belgium sa-nv - paliperidone palmitate 156 mg/ml - eq. paliperidone 100 mg/ml - prolonged-release suspension for injection - 25 mg - paliperidone palmitate 156 mg/ml - paliperidone

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

teva pharma belgium sa-nv - paliperidone palmitate 156 mg/ml - eq. paliperidone 100 mg/ml - prolonged-release suspension for injection - 75 mg - paliperidone palmitate 156 mg/ml - paliperidone

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

teva pharma belgium sa-nv - paliperidone palmitate 156 mg/ml - eq. paliperidone 100 mg/ml - prolonged-release suspension for injection - 100 mg - paliperidone palmitate 156 mg/ml - paliperidone

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

teva pharma belgium sa-nv - paliperidone palmitate 156 mg/ml - eq. paliperidone 100 mg/ml - prolonged-release suspension for injection - 150 mg - paliperidone palmitate 156 mg/ml - paliperidone

New Zealand - English - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - paliperidone palmitate 312 mg/ml equivalent to 175 mg/dose palperidone, as 273 mg/dose paliperidone palmitate;  ;   - suspension for injection - 175 mg - active: paliperidone palmitate 312 mg/ml equivalent to 175 mg/dose palperidone, as 273 mg/dose paliperidone palmitate     excipient: citric acid monohydrate macrogol 4000 monobasic sodium phosphate monohydrate polysorbate 20 sodium hydroxide water for injection - invega trinza, a 3-month injection, is indicated for the maintenance treatment of schizophrenia in adult patients who have been adequately treated with the 1-month paliperidone palmitate injectable product for at least four months.

New Zealand - English - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - paliperidone palmitate 312 mg/ml equivalent to 263 mg/dose palperidone, as 410 mg/dose paliperidone palmitate;  ;   - suspension for injection - 263 mg - active: paliperidone palmitate 312 mg/ml equivalent to 263 mg/dose palperidone, as 410 mg/dose paliperidone palmitate     excipient: citric acid monohydrate macrogol 4000 monobasic sodium phosphate monohydrate polysorbate 20 sodium hydroxide water for injection - invega trinza, a 3-month injection, is indicated for the maintenance treatment of schizophrenia in adult patients who have been adequately treated with the 1-month paliperidone palmitate injectable product for at least four months.

New Zealand - English - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - paliperidone palmitate 312 mg/ml equivalent to 350 mg/dose paliperidone, as 546 mg/dose paliperidone palmitate;  ;   - suspension for injection - 350 mg - active: paliperidone palmitate 312 mg/ml equivalent to 350 mg/dose paliperidone, as 546 mg/dose paliperidone palmitate     excipient: citric acid monohydrate macrogol 4000 monobasic sodium phosphate monohydrate polysorbate 20 sodium hydroxide water for injection - invega trinza, a 3-month injection, is indicated for the maintenance treatment of schizophrenia in adult patients who have been adequately treated with the 1-month paliperidone palmitate injectable product for at least four months.

New Zealand - English - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - paliperidone palmitate 312 mg/ml equivalent to 525 mg/dose paliperidone as 819 mg/dose paliperidone palmitate;  ;   - suspension for injection - 525 mg - active: paliperidone palmitate 312 mg/ml equivalent to 525 mg/dose paliperidone as 819 mg/dose paliperidone palmitate     excipient: citric acid monohydrate macrogol 4000 monobasic sodium phosphate monohydrate polysorbate 20 sodium hydroxide water for injection - invega trinza, a 3-month injection, is indicated for the maintenance treatment of schizophrenia in adult patients who have been adequately treated with the 1-month paliperidone palmitate injectable product for at least four months.

Israel - English - Ministry of Health

teva israel ltd - paliperidone palmitate - suspension for injection extended release - paliperidone palmitate 100 mg / 1 ml - paliperidone - paliperidone teva® is indicated for the acute and maintenance treatment of schizophrenia in adults.paliperidone teva® is indicated for the treatment of schizoaffective disorder as monotherapy and as an adjunct to mood stabilizers and antidepressants.

Israel - English - Ministry of Health

teva israel ltd - paliperidone palmitate - suspension for injection extended release - paliperidone palmitate 100 mg / 1 ml - paliperidone - paliperidone teva® is indicated for the acute and maintenance treatment of schizophrenia in adults.paliperidone teva® is indicated for the treatment of schizoaffective disorder as monotherapy and as an adjunct to mood stabilizers and antidepressants.